In the article, three researchers from the Evidence Based Medicine Renaissance Group outline five problems that come with evidence-based medicine in the current healthcare environment.
1. Vested interests, such as the drug and medical device companies, often fund medical research. This means quality marks or guidelines based on this research may not represent the best clinical practice but rather the treatment option that benefits these companies.
2. The current volume of evidence, especially clinical guidelines, has become almost unmanageable.
3. Statistically significant benefits of one treatment over another may be marginal in clinical practice, but this information may not be included in CDS or other tools.
4. Inflexible treatment recommendations from evidence-based medicine tools may produce care that is management-driven rather than patient-centered.
5. Evidence-based guidelines often map poorly to complex cases where the patient has multiple co-morbidities.
More Articles on Evidence-Based Medicine:
7 Recently Launched mHealth Apps
CHE Trinity Health’s 4 Steps to Implementing Evidence-Based Guidelines
New Watson-Powered App the “Ultimate Research Assistant”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
